Lifeboat Foundation

Today, we want to spotlight a recent study showing that boosting nicotinamide adenine dinucleotide (NAD+) levels in mice prevents age-related hearing loss.

What is β-Lapachone?

β-Lapachone is a quinone-containing compound that was originally isolated from the lapacho tree in South America. It is worth noting that this tree has been used as a herbal medicine for a number of South and Central American indigenous peoples and that the bark of the tree is sometimes used for making a herbal tea called taheebo.

From computer hacking to biohacking, Dave Asprey has embarked on a quest to reverse the aging process.

In the 2015 movie “Chappie”, which is set in the near future, automated robots comprise a mechanised police force. An encounter between two rival criminal gangs severely damages the law enforcing robot (Agent 22). His creator Deon recommends dismantling and recycling the damaged police droids. However, criminals kidnap Deon and force him to upload human consciousness into the damaged robot to train it to rob banks. Chappie becomes the first robot with the human mind who can think and feel like a human. Later, in the movie when his creator Deon is dying, it’s Chappie’s turn to upload Deon’s consciousness into a spare robot through a neural helmet. Similarly, in the “Avatar” a 2009 Hollywood science fiction, a character in the film by name Grace connects with Eiwa, the collective consciousness of the planet and transfers her mind to her Avatar body, while another character Jake transfers his mind to his Avatar body rendering his human body lifeless.

Mind uploading is a process by which we relocate the mind, an assemblage of memories, personality, and attributes of a specific individual, from its original biological brain to an artificial computational substrate. Mind uploading is a central conceptual feature of many science fiction novels and films. For instance, Hanson’s book titled “The Age of Em: Work, Love and Life when Robots Rule the Earth” is a 2016 nonfiction book which explores the implications of a future world when researchers have learned to copy humans onto computers, creating “ems,” or emulated people, who quickly come to outnumber the real ones.

UK company raises $100m to find fountain of ‘eternal youth’ by cheating death and REVERSING ageing with new technology…

The firm announced a total investment of $10 million from its founders and a further $10 million each from core investors.

It seems that billionaire biotech investor Jim Mellon is the flavor of the month as he continues the drive to create a rejuvenation biotech industry. Jim and his colleagues at Juvenescence have announced that they have secured another $100M for the company, and it will be used to invest and support the growth of promising biotech companies working in this field.

Juvenescence has a varied investment portfolio of companies that range in potential usefulness, depending on your point of view, and they mostly favor the more traditional small molecule drug approach. There are a few companies that are of particular interest.

UK biotech valued at $500m and aiming for IPO next year.

People say, well, but we’re going to stop being human if we merge with machines. No, that is what it means to be human.

Dr. Kurtzweil, I would like to ask you. You have made hundreds of predictions out of which many already have come true, and with no doubt many more will come through. But if you would have to single out your three most important predictions for the upcoming decade, what would they be?

Continue reading “Ray Kurzweil: Enhanced Longevity by 2030” »

In 2006, scientists discovered a way to “reprogram” mature cells—adult skin cells, for example—into stem cells that could, in principle, give rise to any tissue or organ in the body. Many assumed it was only a matter of time until this groundbreaking technique found its way into the clinic and ushered in a regenerative medicine revolution.

Because the same patient would be both the donor and the recipient of cells derived from these so-called induced pluripotent stem cells (iPSCs), these cells would be seen as “self” by the immune system, the thinking went, and not subject to the problems of rejection that plague conventional transplants.

But iPSCs haven’t emerged as the cure-all that was originally envisioned, due to unforeseen setbacks, including the surprising preclinical finding that iPSC-derived cell transplants are often rejected, even after being reintroduced into the organism the cells were sourced from.